of products with the high waste during production still higher than standard setting. 3. Selling expenses For Quarter 1 of the year 2020, the selling expenses was 2.99 million baht or 3.05% from sale
and cash equivalents in the amount of THB 450.39 million. This was pursuant to the Company’s policy in maintaining liquidity and setting aside cash reserves to be used as working capital in order to
, household purchasing power saw limited recovery. Under these circumstances, the Thai economy in this quarter may grow at a slower pace of 3.2 percent over-year, which is also less than the 3.7 percent growth
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
disruption due to several declared force majeure and the North American PTA and PET industry is facing acute acetic acid and MEG shortage, highlighting the advantage of IVL’s integrated model. 4 Our downstream
control power to the Company Items 31 December 2016 Revenue 1,347.66 Operating expenses Operating expenses 2,587,653.58 Total Expenses 2,587,653.58 OPERATING INCOME (LOSS) (2,586,305.92) บมจ.0107537002109
Shares of Hero Experience equivalent to 32.5 percent of the registered capital of Hero Experience, which do not confer the control power to the Company - 872,370 ordinary shares in Hero Experience
, which do not confer the control power to the Company - 1,006,580 ordinary shares in Hero Experience, representing 37.5 percent of the registered capital of Hero Experience. - 37.5 percent rights to
still intense competition together with exchange rate fluctuations causing the sales of this product of the company to decrease. However, the company expects that with the strength of sale channel and